How does Maersk ensure compliance to GDP?
Good Distribution Practices (GDP) describe the quality assurance which ensures that the quality of pharmaceutical products is maintained throughout all stages of the supply chain from site of manufacturer to the pharmacy or person authorised or entitled to supply medicinal products to the public. (Source: EU GDP Guidelines (2013/C 343/01) 5th November 2013)
Maersk Quality Management System dedicated to our Pharma Cold Chain Management customers ensures our services address and comply to all GDP requirements.
Sorry there was an error
Was this information useful?
Thanks for your feedback!
Sorry we couldn't help more, please review the related FAQs below.
We're sorry you were unable to find what you wanted to today
Please use one of the below options to contact our Customer Experience teams
Related FAQs
What does a connected cold chain mean? Can I get access to Quality Management System documentation? Can I protect my cargo financially against accidental damage during its cold journey with Maersk? What is Maersks Corrective Action / Preventative Actions (CAPA) procedures? What is the difference between consolidation and deconsolidation? My business is growing and my cold supply chain is getting more complex, can Maersk Cold Chain Logistics help me with simplifying my Cold Supply Chain? How is GDP and Quality integrated into Maersk P-CCM? What is the coverage of your visibility and tracking services? Can I see and follow the temperature of my pharmaceutical shipments? What are the benefits of Maersk Cold Storage facilities? What are Maersk's Cold Chain Solutions? What are the capabilities of the CCM platform?New to Maersk.com?
Step by step guides to get started using our digital services.